Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLeukemiaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLeukemiaTeam Member asked a question πŸ’­
Sacramento, CA
April 27, 2024
 · 
Be the first to react
A MyLeukemiaTeam Member

One of my team mates @A MyLeukemiaTeam Member might be a good add for your team.

April 27, 2024
MyLeukemiaTeam

Living with T-cell prolymphocytic leukemia (T-PLL) can be quite challenging due to its aggressive nature. Here are some insights based on experiences shared by individuals with T-PLL:

1. **Support Networks**: Engaging with communities like MyLeukemiaTeam can be beneficial. This platform allows individuals to connect with Show Full Answer

Living with T-cell prolymphocytic leukemia (T-PLL) can be quite challenging due to its aggressive nature. Here are some insights based on experiences shared by individuals with T-PLL:

1. **Support Networks**: Engaging with communities like MyLeukemiaTeam can be beneficial. This platform allows individuals to connect with others who understand their condition, share experiences, and receive emotional support.

2. **Treatment Journey**: Many patients undergo treatments that may lead to complete remission, but relapse is common. Treatments might include chemotherapy, and for those who achieve complete remission, a hematopoietic stem cell transplantation might be recommended to reduce the rate of relapse.

3. **Clinical Trials**: New treatments, including drugs like Venclexta (venetoclax) which prevents T cells from maturing and dividing, are being studied. Participation in clinical trials can be a way to access these emerging therapies.

4. **Monitoring**: Regular testing is crucial to evaluate treatment progress. This includes blood counts, differential counts, and possibly bone marrow evaluations.

5. **Symptoms Management**: Symptoms like anemia, effusions, hepatomegaly, lymphadenopathy, splenomegaly, thrombocytopenia, unintentional weight loss, night sweats, and fever need to be managed actively.

6. **Prognosis**: The prognosis for T-PLL is generally poor, with an average life expectancy from the time of diagnosis being about 19 months, although this can vary based on individual circumstances and response to treatment.

It's important for anyone dealing with T-PLL to have close medical supervision and to discuss all available treatment options, including clinical trials, with their healthcare provider.

April 27, 2024
A MyLeukemiaTeam Member

Thank you Cathryn. Hope you have a great Sunday! 😊

April 28, 2024
A MyLeukemiaTeam Member

Hello Bigeyes
I have TPLL...was diagnosed November 2022. I remained asymptomatic until last summer. In December, I was accepted in a research program for TPLL and taking a kinase inhibitor. My numbers have responded very well to the drug.
I would be happy to answer any questions you might have so I added you to my team. 😊

April 28, 2024

Related Questions

View All
A MyLeukemiaTeam Member asked a question πŸ’­
Maryland Heights, MO

A MyLeukemiaTeam Member asked a question πŸ’­
NC

A MyLeukemiaTeam Member asked a question πŸ’­
Sacramento, CA